REGINfo: Sanofi-Aventis - Pharmacie - Financial information

SEARCH BY

Issuer directory

KEYWORDS

COMPANIES / ISIN

TYPE OF INFORMATION

INDUSTRY

ADVANCED SEARCH

COMPARTMENTS / INDICES

France

America

Asia

Oceania

> ASX 20
Australia - ASX 20
> NZX 15
New Zealand - NZX 15

Africa

> FTSE/JSE...
South Africa - FTSE/JSE Top 40
> TA 25
Israel - TA 25
- ALONY HETZ
- AZRIELI GROUP
- BAZAN
- BEZEQ
- DELEK DRILLIN
- DELEK GROUP
- DISCOUNT
- ELBIT SYSTEMS
- Energean Oil Gas
- FIBI BANK
- GAZIT GLOBE
- HAREL
- ICL
- IFF
- ISRAEL CORP
- LEUMI
- LivePerson
- MIZRAHI TEFAHOT
- NICE
- OPKO HEALTH
- ORMAT
- PAZ OIL
- PERRIGO
- Phoenix Group Holdings
- POALIM
- SHUFERSAL
- STRAUSS GROUP
- TEVA
- TOWER JAZZ

Europe

COMPANY SEARCH RESULT

$Sanofi-Aventis: Click to view the issuer\'s details$

Last update : 29/03/2019 >View issuer details

2021.02.22 | 19:00 | Permanent Information Releases / General Company News

puce FDA approves Libtayo® (cemiplimab-rwlc) monotherapy for patients with first-line advanced non-small cell lung cancer with PD-L1 expression of =50% - HTML (w)

2021.02.22 | 19:00 | Permanent Information Releases / General Company News

puce La FDA approuve Libtayo® (cemiplimab-rwlc) en monothérapie pour le traitement de première ligne du cancer du poumon non à petites cellules dont 50 % ou plus des cellules tumorales expriment la protéine PD-L1 - HTML (w)

2021.02.22 | 18:00 | Share History / Voting Rights and Number of Shares

puce Sanofi: Information concerning the total number of voting rights and shares - January 2021 - HTML (w)

2021.02.22 | 18:00 | Share History / Voting Rights and Number of Shares

puce Sanofi : Informations relatives au nombre total de droits de vote et d’actions - Janvier 2021 - HTML (w)

2021.02.22 | 11:40 | Permanent Information Releases / General Company News

puce Sanofi and GSK initiate new Phase 2 study of their adjuvanted recombinant protein-based COVID-19 vaccine candidate - HTML (w)

2021.02.22 | 11:40 | Permanent Information Releases / General Company News

puce Sanofi et GSK débutent une nouvelle étude de phase II consacrée à leur candidat-vaccin à protéine recombinante avec adjuvant contre la COVID-19 - HTML (w)

2021.02.12 | 07:00 | Permanent Information Releases / General Company News

puce The Lancet publishes Libtayo® (cemiplimab) data showing extended overall survival in patients with first-line advanced non-small cell lung cancer with PD-L1 expression of ³50% - HTML (w)

2021.02.12 | 07:00 | Permanent Information Releases / General Company News

puce The Lancet publie des données sur Libtayo® (cémiplimab) montrant un prolongement de la survie globale chez des patients atteints d’un cancer du poumon non à petites cellules dont 50 % ou plus des cellules tumorales expriment la protéine PD- - HTML (w)

2021.02.09 | 23:15 | Permanent Information Releases / General Company News

puce FDA approves Libtayo® (Cemiplimab-rwlc) as first immunotherapy indicated for patients with advanced basal cell carcinoma - HTML (w)

2021.02.09 | 23:15 | Permanent Information Releases / General Company News

puce La FDA approuve Libtayo® (cemiplimab-rwlc), premier médicament d’immunothérapie indiqué pour le traitement des patients atteints d’un carcinome basocellulaire au stage avancé - HTML (w)

2021.02.05 | 07:30 | Permanent Information Releases / General Company News

puce Capital Markets Day 2021: Sanofi progresses on its strategy to drive growth across its businesses and innovation with emerging leadership in immunology - HTML (w)

2021.02.05 | 07:30 | Permanent Information Releases / General Company News

puce Capital Markets Day 2021 : Progression de la stratégie de Sanofi pour dynamiser la croissance de ses activités et son innovation, et émergence d’un leadership en immunologie - HTML (w)

2021.02.05 | 07:30 | Permanent Information Releases / General Company News

puce Sanofi delivered close to double-digit Q4 2020 business EPS(1) growth at CER - HTML (w)

2021.02.05 | 07:30 | Permanent Information Releases / General Company News

puce T4 2020: Croissance du BNPA des activités(1) de près de 10% à TCC - HTML (w)

2021.01.26 | 18:00 | Share History / Voting Rights and Number of Shares

puce Sanofi: Information concerning the total number of voting rights and shares - December 2020 - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 3032